Respiratory Inhalers Market is Expected to Grow at a CAGR of 5.38% and Reach $47.83 Billion by 2026, DelveInsight Analysis

LA VEGAS, March 17, 2022 /PRNewswire/ — DelveInsight Respiratory Inhalers Market Overview and Forecast The report provides the current and forecast Respiratory Inhaler market, upcoming device innovations, individual market shares, challenges, drivers and barriers, market trends and key competitors in the Respiratory Inhaler market.

Some of the salient features of the Respiratory Inhalers Market report:

  • According to DelveInsight’s analysis, in terms of revenue share, North America is expected to register the fastest growth in the respiratory inhalers market.
  • Key Respiratory Inhaler Market players proactively working in the field include names such as Novartis AG, AstraZeneca, GlaxoSmithKline plc, CHIESI Farmaceutici SpA, Lupin, Zydus Cadila, Teva Pharmaceutical Industries Ltd., OMRON, Koninklijke Philips NV, PARI GmbH, Boehringer Ingelheim International GmbH., Glenmark Pharmaceuticals Limited, Lepu Medical Technology(beijing)Co., Ltd., Rossmax International Ltd, Promed Technology Co., Limited, HELTMAN Medikal AS, Respiratory Pneuma., Cipla Inc., Microlife Corporation., Honsun, and others.
  • DelveInsight analyzes that the global respiratory inhalers market is expected to reach $47.83 billion by 2026 growing to a CAGR of 5.38% during the forecast period from 2021 to 2026.
  • In September 2020GlaxoSmithKline plc and Innoviva, Inc.. received FDA approval for Trelegy Ellipta as the first single-inhaler, once-daily triple therapy for the treatment of asthma and COPD in the United States.
  • In July 2020Novartis has received approval from the European Commission (EC) for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside the treatment of uncontrolled asthma in the EU.
  • In January 2020Aptar Pharma has teamed up with Lupine to launch india first smart connected device for respiratory diseases, ADHERO.
  • in May 2020Propeller Health, a leading digital health company dedicated to asthma and COPD management has received FDA clearance to make its connected platform available AstraZeneca Symbicort to help digitize the treatment of asthma and chronic obstructive pulmonary disease (COPD).
  • in May 2020Iconovo has received CE Mark approval for its ICOcap™ Capsule Dry Powder Inhaler for use in clinical trials.
  • In July 2020Respiratory Teva, LLC., a US subsidiary of Teva Pharmaceutical Industries Ltd. spear ProAir® Digihaler® (albuterol sulfate 117 mcg) Inhalation powder for patients with asthma and COPD.

To choose the latest highlights related to respiratory inhalers, get the snapshot of major highlights involved in the Respiratory Inhalers Market Report

Overview of Respiratory Inhalers

Breathing inhalers are portable devices used to deliver medication for obstructive airway diseases such as chronic obstructive pulmonary disorder (COPD), asthma, among others, into the airways. Inhaled pharmacological therapies are the cornerstone of the treatment and prevention of patients with asthma and COPD. Inhalers offer the advantage of avoiding systemic drug exposure and are delivered topically to the airways, leading to local efficacy in the lungs compared to oral or parenteral formulations. Generally, respiratory inhalers are of four types: pressurized metered dose inhalers (pMDIs), dry powder inhalers (DPIs), slow mist inhalers (SMIs), and nebulizers.

Respiratory Inhaler Market Overview

Among all regions, North America is expected to occupy a major share of the overall respiratory inhaler market in the coming years. This dominance is due to the increasing prevalence of COPD in the region. In addition, increasing adoption of technologically advanced respiratory inhalers, growing launches of inhaler-related products in the region, presence of well-established healthcare institutions, and growing government initiatives to raise awareness of respiratory disorders and their proper management in the region, along with the presence of key respiratory inhaler companies is expected to drive up the respiratory inhaler market.

For example, on December 07, 2020AireHealth, an innovative digital health company has received 510(k) clearance from the FDA for its connected nebulizer.

Click here to learn more about the Respiratory Inhaler Market Landscape @ Respiratory Inhaler Market Assessment

Respiratory Inhaler Market Dynamics

The global respiratory inhalers market is expected to witness significant growth owing to the growing approval and launches of various technological products in the respiratory inhaler market. Besides, degradation of air quality and increased air pollution, growing awareness of inhalers and their use for controlling respiratory disorders, and a increase in smoking among the population across the world would contribute to the rise of the respiratory inhalers market. Besides, growing efforts of key players for raise awareness about the use of inhalers in the control of various obstructive airway diseases are also expected to increase the adoption of respiratory inhalers among the patient population, thereby strengthening the respiratory inhaler market over the forecast period. Besides, decrease in air quality in industrialized areas due to increasing air pollution is also a key factor propelling the respiratory inhalers market.

COVID-19 pandemic has had a limited effect on Respiratory Inhalers Market. During the initial phase of the pandemic due to the implementation of a strict nationwide lockdown, various healthcare facilities were disrupted. However, it is estimated that people severely affected by COVID-19 infection may develop respiratory disease as a side effect that will increase the demand for respiratory inhalers among recovering COVID patients. Additionally, various clinical trials are currently underway to study the effectiveness of asthma inhalers on patients with COVID-19. Moreover, te launch of vaccines and their administration across the world will normalize the respiratory inhaler market situation in the post-pandemic situation.

To better understand the impact of COVID-19 on respiratory inhalers, get an overview of the Respiratory Inhaler Market Analysis

Scope of the Respiratory Inhalers Market Report

  • Blanket: Global
  • Study period: 2021-2026
  • Market segmentation by product type – Dry powder inhaler, metered dose inhaler, soft mist inhalers, nebulizers [Ultrasonic Nebulizers, Mesh Nebulizers, And Compressor Nebulizers
  • Market Segmentation By Type – Conventional Inhaler Devices And Smart Inhaler Devices
  • Market Segmentation By Patient Type- Adult And Pediatrics
  • Market Segmentation By Indication– Asthma, COPD, And Others
  • Market Segmentation By Geography – North America, Europe, Asia-Pacific, and Rest of World
  • Key Respiratory Inhalers Companies – Novartis AG, AstraZeneca, GlaxoSmithKline plc, CHIESI Farmaceutici S.p.A., Lupin, Zydus Cadila, Teva Pharmaceutical Industries Ltd., OMRON, Koninklijke Philips N.V., PARI GmbH, Boehringer Ingelheim International GmbH., Glenmark Pharmaceuticals Limited, Lepu Medical Technology(Beijing)Co., Ltd., Rossmax International Ltd, Promed Technology Co., Limited, HELTMAN Medikal A.S., Pneuma Respiratory., Cipla Inc., Microlife Corporation., Honsun,  and others.
  • Porter’s Five Forces Analysis
  • Product Profiles
  • Case Studies 
  • KOL’s Views
  • Analyst’s View

Delveinsight Analysis: The Global Respiratory Inhalers market is expected to reach USD 47.83 billion by 2026 growing at a (Compound Annual Growth Rate) CAGR of 5.38% during the forecast period from 2021 to 2026.

Know more about which MedTech player is set to emerge as the trendsetter @ Respiratory Inhalers Market Landscape Analysis 

Table of Contents 

1

Respiratory Inhalers Market Report Introduction

2

Respiratory Inhalers Market Executive summary

3

Regulatory and Patent Analysis

4

Respiratory Inhalers Market Key Factors Analysis

5

Respiratory Inhalers Market Porter’s Five Forces Analysis

6

COVID-19 Impact Analysis on Respiratory Inhalers Market

7

Respiratory Inhalers Market Layout

8

Respiratory Inhalers Market Global Company Share Analysis – Key 3-5 Companies

9

Respiratory Inhalers Market Company and Product Profiles


9.1 Novartis AG

9.2 AstraZeneca

9.3 GlaxoSmithKline plc

9.4 CHIESI Farmaceutici S.p.A.

9.5 Lupin

9.6 Zydus Cadila

9.7 Teva Pharmaceutical Industries Ltd.

9.8 OMRON

9.9 Koninklijke Philips N.V.

9.10 PARI GmbH

10

Project Approach

11

KOL Views

12

DelveInsight Capabilities

13

Disclaimer

14

About DelveInsight

Learn more about the report offerings @ Respiratory Inhalers Market Outlook

Pulse Oximeters Market

DelveInsight’s ‘Pulse Oximeters Market Insights, Competitive Landscape and Market Forecast – 2026’ report deliver an in-depth understanding of Pulse Oximeters, historical and forecasted Pulse Oximeters market trends, market drivers, market barriers, and key companies involved like Medtronic, Nonin Medical Inc, Lepu Medical Technology, TytoCare Ltd, VYAIRE, OMRON Corporation. Meditech Equipment Co ., Ltd, and several others.

Cough Assist Devices Market

“DelveInsight’s ‘Cough Assist Devices Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Cough Assist Devices and the historical and forecasted Cough Assist Devices market trends, market drivers & barriers, unmet needs and key companies involved such as Koninklijke Philips N.V, Percussionaire Corp., Emerson, Hill Rom, Dima Italia SRL, and many more.

Cough in Idiopathic Pulmonary Fibrosis Market 

DelveInsight’s ‘Cough in Idiopathic Pulmonary Fibrosis (IPF)-Market Insights, Epidemiology and Market Forecast– 2030’ report delivers an in-depth understanding of the cough in IPF, historical and forecasted epidemiology as well as the Cough in IPF market trends, market drivers & barriers, unmet needs and key companies involved such as Algernon Pharmaceuticals, Trevi Therapeutics, Nerre Therapeutics, and others.

Chronic Obstructive Pulmonary Disease Market

DelveInsight’s ‘Chronic Obstructive Pulmonary Disease (COPD)-Market Insights, Epidemiology, and Market Forecast–2030’ report deliver an in-depth understanding of the Chronic Obstructive Pulmonary Disease (COPD), historical and forecasted epidemiology as well as the Chronic Obstructive Pulmonary Disease (COPD) market trends, market drivers & barriers, unmet needs and key companies involved such as AstraZeneca, Amgen, Circassia Pharmaceuticals Inc, Biomarck Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Chiesi Farmaceutici, Genentech, GlaxoSmithKline, Theravance, Innoviva, Inmunotek, Mereo BioPharma, Novartis Pharmaceuticals, and several others.

Airway Management Devices Market

Global Airway Management Devices Market was valued at USD 1.51 billion in 2020, growing at a CAGR of 6.20% during the forecast period from 2021 to 2026, to reach USD 2.35 billion by 2026. The report delivers an in-depth understanding of the Airway Management Devices, historical and forecasted epidemiology as well as key companies involved in pipelines such as Smiths Medical PLC, Narang Medical Limited, Intersurgical Ltd, Teleflex Incorporated, Stryker Corporation, Medtronic PLC, and others.

Asthma Diagnostic Devices Market

“DelveInsight’s ‘Asthma Diagnostic Devices Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Asthma Diagnostic Devices and the historical and forecasted Asthma Diagnostic Devices market trends, drivers, barriers, and key companies involved such as Medline Industries, Becton, Dickinson and Company, Siemens Process Instrumentation, Smiths Medical, Vyaire Medical, Nihon Kohden Corporation, Vitalograph, Circassia Limited, Intermedical (UK) Limited, and several others.

Chronic Obstructive Pulmonary Disease Treatment Devices Market

“DelveInsight’s ‘Chronic Obstructive Pulmonary Disease Treatment Devices Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Chronic Obstructive Pulmonary Disease Treatment Devices and the historical and forecasted Chronic Obstructive Pulmonary Disease Treatment Devices market trends, drivers, barriers and key companies involved such as GlaxoSmithKline plc, Novartis AG, Merck & Co., Koninklijke Philips N.V, AstraZeneca, 3M, GF HEALTH PRODUCTS, Sunovion Pharmaceuticals Inc, Smiths Medical, Baxter, and others.

Other Trending Reports

Chronic Myelocytic Leukemia CML Market 
Congenital Hyperinsulinism Market
Diabetes Insipidus Market 
Limbal Stem Cells Deficiency Market 
Syncope Market 
Proteus Syndrome Market 
Intestinal Obstruction Market 
Allergic Asthma Due to Dermatophagoides Farinae Market 
Bag3-related Gene Therapies Market
Tay-Sachs Market

Interested to know more about the breakthrough happenings? Take a look at the posts below 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect With Us at LinkedIn | Facebook | Twitter

Contact Us
Shruti Thakur
[email protected]
+1(919)321-6187
www.delveinsight.com

SOURCE DelveInsight Business Research, LLP